Abbott Laboratories’s (NYSE:ABT) Q3 2026 earnings results: revenue in line with expectations
Published . Updated .
Abbott Laboratories’s (NYSE:ABT) Q3 2026 earnings results: revenue in line with expectations StockStory
Directly affected
- ABT Abbott Laboratories
Named in this report.
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Abbott Laboratories’s (NYSE:ABT) Q3 2026 earnings results: revenue in line with expectations StockStory
Source: StockStory
This story
12 out of 100
“Abbott Laboratories’s (NYSE:ABT) Q3 2026 earnings results: revenue in line with expectations” scores 12 out of 100. The score uses 1 sources.